Cite
HARVARD Citation
Nussbaumer-Pröll, A. et al. (2020). Low pH reduces the activity of ceftolozane/tazobactam in human urine, but confirms current breakpoints for urinary tract infections. Journal of antimicrobial chemotherapy. pp. 593-599. [Online].